Pacira BioSciences (PCRX) Research & Development (2010 - 2026)
Pacira BioSciences (PCRX) posted Research & Development of $30.24 million for Q2 2026, up 7.2% from $28.2 million a year earlier and up 7.7% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Research & Development (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Pacira BioSciences was $121.73 million, up 26.1% year-over-year; for FY2025, it came in at $117.31 million, up 43.8% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
- In prior years, Pacira BioSciences' Research & Development was $81.58 million in FY2024 (+7.0%), $76.26 million in FY2023 (-10.1%), $84.8 million in FY2022 (+52.7%) and $55.55 million in FY2021 (-6.5%).
- Quarterly Research & Development has run from a low of $11.58 million in Q3 2021 to a high of $37.45 million in Q4 2025 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last seven quarters, with growth averaging 25.3% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2022, with growth of 109.0%; the weakest was Q2 2023, with a decline of 28.4%.
- According to Business Quant data, Research & Development for the three prior quarters was $28.07 million (Q1 2026), $37.45 million (Q4 2025) and $25.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Pacira BioSciences | 1.01 Bn | 73.12 Mn | 148.24 Mn | 30.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.24 Mn |
| Mar 31, 2026 | 28.07 Mn |
| Dec 31, 2025 | 37.45 Mn |
| Sep 30, 2025 | 25.97 Mn |
| Jun 30, 2025 | 28.20 Mn |
| Mar 31, 2025 | 25.34 Mn |
| Dec 31, 2024 | 23.90 Mn |
| Sep 30, 2024 | 19.10 Mn |
| Jun 30, 2024 | 20.34 Mn |
| Mar 31, 2024 | 18.24 Mn |
| Dec 31, 2023 | 19.46 Mn |
| Sep 30, 2023 | 20.83 Mn |
| Jun 30, 2023 | 18.82 Mn |
| Mar 31, 2023 | 17.14 Mn |
| Dec 31, 2022 | 17.51 Mn |
| Sep 30, 2022 | 19.41 Mn |
| Jun 30, 2022 | 26.28 Mn |
| Mar 31, 2022 | 21.61 Mn |
| Dec 31, 2021 | 15.51 Mn |
| Sep 30, 2021 | 11.58 Mn |
API Access
Pacira BioSciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();